208 related articles for article (PubMed ID: 35227188)
1. Review on Different Vesicular Drug Delivery Systems (VDDSs) and Their Applications.
Alenzi AM; Albalawi SA; Alghamdi SG; Albalawi RF; Albalawi HS; Qushawy M
Recent Pat Nanotechnol; 2023; 17(1):18-32. PubMed ID: 35227188
[TBL] [Abstract][Full Text] [Related]
2. Nanovesicles-Mediated Drug Delivery for Oral Bioavailability Enhancement.
Ren Y; Nie L; Zhu S; Zhang X
Int J Nanomedicine; 2022; 17():4861-4877. PubMed ID: 36262189
[TBL] [Abstract][Full Text] [Related]
3. Addressing the Superior Drug Delivery Performance of Bilosomes─A Microscopy and Fluorescence Study.
Mondal D; Mandal RP; De S
ACS Appl Bio Mater; 2022 Aug; 5(8):3896-3911. PubMed ID: 35924346
[TBL] [Abstract][Full Text] [Related]
4. Niosomes: a controlled and novel drug delivery system.
Rajera R; Nagpal K; Singh SK; Mishra DN
Biol Pharm Bull; 2011; 34(7):945-53. PubMed ID: 21719996
[TBL] [Abstract][Full Text] [Related]
5. Vesicular Approach Review on Nanocarriers bearing Curcumin and Applications.
Upadhyay P; Singh D; Upadhyay S
Recent Adv Drug Deliv Formul; 2022 Apr; ():. PubMed ID: 35379164
[TBL] [Abstract][Full Text] [Related]
6. Cubosomes: An Emerging and Promising Drug Delivery System for Enhancing Cancer Therapy.
Singh S; Sachan K; Verma S; Singh N; Singh PK
Curr Pharm Biotechnol; 2024; 25(6):757-771. PubMed ID: 37929730
[TBL] [Abstract][Full Text] [Related]
7. Solid lipid nanoparticles for hydrophilic drugs.
Mirchandani Y; Patravale VB; S B
J Control Release; 2021 Jul; 335():457-464. PubMed ID: 34048841
[TBL] [Abstract][Full Text] [Related]
8. Vesicular approach of cubosomes, its components, preparation techniques, evaluation and their appraisal for targeting cancer cells.
Iqbal S; Zaman M; Waqar MA; Sarwar HS; Jamshaid M
J Liposome Res; 2024 Jun; 34(2):368-384. PubMed ID: 37873797
[TBL] [Abstract][Full Text] [Related]
9. Niosomes from 80s to present: the state of the art.
Marianecci C; Di Marzio L; Rinaldi F; Celia C; Paolino D; Alhaique F; Esposito S; Carafa M
Adv Colloid Interface Sci; 2014 Mar; 205():187-206. PubMed ID: 24369107
[TBL] [Abstract][Full Text] [Related]
10. A Discursive Review of Recent Development and Patents on Glycerosomes.
Singh R; Zeeshan F; Srivastava D; Awasthi H
Recent Pat Nanotechnol; 2023; 17(3):183-189. PubMed ID: 35346018
[TBL] [Abstract][Full Text] [Related]
11. Unlocking the Potential of Bilosomes and Modified Bilosomes: a Comprehensive Journey into Advanced Drug Delivery Trends.
Nayak D; Rathnanand M; Tippavajhala VK
AAPS PharmSciTech; 2023 Nov; 24(8):238. PubMed ID: 37989979
[TBL] [Abstract][Full Text] [Related]
12. Niosomes as a propitious carrier for topical drug delivery.
Hamishehkar H; Rahimpour Y; Kouhsoltani M
Expert Opin Drug Deliv; 2013 Feb; 10(2):261-72. PubMed ID: 23252629
[TBL] [Abstract][Full Text] [Related]
13. Ethosomes and Transfersomes: Principles, Perspectives and Practices.
Garg V; Singh H; Bimbrawh S; Singh SK; Gulati M; Vaidya Y; Kaur P
Curr Drug Deliv; 2017; 14(5):613-633. PubMed ID: 27199229
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in non-ionic surfactant vesicles (niosomes): Fabrication, characterization, pharmaceutical and cosmetic applications.
Chen S; Hanning S; Falconer J; Locke M; Wen J
Eur J Pharm Biopharm; 2019 Nov; 144():18-39. PubMed ID: 31446046
[TBL] [Abstract][Full Text] [Related]
15. Formulation Development and Evaluation of Novel Vesicular Carrier for Enhancement of Bioavailability of Poorly Soluble Drug.
Sharma S; Bhatt S; Saini V
Pharm Nanotechnol; 2021; 9(1):70-82. PubMed ID: 33231151
[TBL] [Abstract][Full Text] [Related]
16. Thermo-responsive lipophilic NIPAM-based block copolymers as stabilizers for lipid-based cubic nanoparticles.
Balestri A; Lonetti B; Harrisson S; Farias-Mancilla B; Zhang J; Amenitsch H; Schubert US; Guerrero-Sanchez C; Montis C; Berti D
Colloids Surf B Biointerfaces; 2022 Dec; 220():112884. PubMed ID: 36209550
[TBL] [Abstract][Full Text] [Related]
17. Cubosomes as an emerging platform for drug delivery: a review of the state of the art.
Abourehab MAS; Ansari MJ; Singh A; Hassan A; Abdelgawad MA; Shrivastav P; Abualsoud BM; Amaral LS; Pramanik S
J Mater Chem B; 2022 Apr; 10(15):2781-2819. PubMed ID: 35315858
[TBL] [Abstract][Full Text] [Related]
18. Vaginal Drug Delivery Systems to Control Microbe-Associated Infections.
Xie L; Li Y; Liu Y; Chai Z; Ding Y; Shi L; Wang J
ACS Appl Bio Mater; 2023 Sep; 6(9):3504-3515. PubMed ID: 36932958
[TBL] [Abstract][Full Text] [Related]
19. Biocompatible Nanovesicular Drug Delivery Systems with Targeting Potential for Autoimmune Diseases.
Neupane YR; Mahtab A; Siddiqui L; Singh A; Gautam N; Rabbani SA; Goel H; Talegaonkar S
Curr Pharm Des; 2020; 26(42):5488-5502. PubMed ID: 32445443
[TBL] [Abstract][Full Text] [Related]
20. Vesicular drug delivery for the treatment of topical disorders: current and future perspectives.
Witika BA; Mweetwa LL; Tshiamo KO; Edler K; Matafwali SK; Ntemi PV; Chikukwa MTR; Makoni PA
J Pharm Pharmacol; 2021 Oct; 73(11):1427-1441. PubMed ID: 34132342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
